Bromodomain inhibitors
The present invention provides for compounds of formula (I) wherein Y1, Y2, R1, R2, R3, A1, A2, A3, and A4, have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents for the treatment of diseases and conditions, including inflammato...
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
02.10.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention provides for compounds of formula (I) wherein Y1, Y2, R1, R2, R3, A1, A2, A3, and A4, have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents for the treatment of diseases and conditions, including inflammatory diseases, cancer, and AIDS. Also provided are pharmaceutical compositions comprised of one or more compounds of formula (I). |
---|---|
Bibliography: | Application Number: US201615216855 |